Asthmatin 10

Montelukast inhibits physiologic actions of LTD4 at the CysLT1 receptor without any agonist activity.

Pack size Box of 7 tablets, 14 tablets, 30 tablets. Bottle of 28 tablets.
Shelf-life 24 months
Composition Montelukast.
Dosage forms and strengths Film-coated tablet: 10 mg.
Product code :



  • The prophylasis and chronic treatment of asthma in adults and pediatric patients 12 months of age and older.
  • The relief of symptoms of seasonal allergic rhinitis in adults and pediatric patients 2 years of age and older, and perennial allergic rhinitis in adults and pediatric patients 6 months of age and older.


  • Asthmatin should be taken once daily.
  • Asthma or allergic rhinitis: adult and adolescents ≥ 15 years of age: 10 mg; pediatric patients 6 to 14 years of age: 5 mg, 2 to 5 years old: 4 mg.
  • Pediatric patients 12 to 23 months of age with asthma, 6 to 23 months of age with perennial allergic rhinitis: 4 mg.
  • Safety and effectiveness in pediatric patients younger than 6 months of age with perennial allergic rhinitis and in patients less than 12 months of age with asthma have not established.


  • For asthma or both asthma and allergic rhinitis, should take in the evening.
  • For allergic rhinitis, the time of administration may be individualized to suit patient needs.

Known hypersensitivity to any of the active substance or excipients.

Very common: upper respiratory infection, hypersensitivity reactions including anaphylaxis.

Common: Diarrhoea, nausea, vomiting; elevated levels of ALT, AST; rash; pyrexia.

Bronchospasm in acute asthma attacks.

Patients with rare hereditary problems of galactose intolerance, the Lapp lactase deficiency or glucose-galactose malabsorption

Montelukast should not be abruptly substituted for inhaled or oral corticosteroids.

Montelukast should not be used as monotherapy for the treatment and management of
exercise-induced bronchospasm.

Patients with known aspirin sensitivity should continue avoidance of aspirin/NSAIDs while taking montelukast.

Montelukast should be used during pregnancy only if clearly essential. Caution should be exercised when montelukast is given to a nursing mother.

Patients should be aware of how they react to drug before driving or operating machinery.